发明授权
US08394801B2 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
失效
喹喔啉衍生物及其用于治疗良性和恶性肿瘤疾病的用途
- 专利标题： Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
- 专利标题（中）： 喹喔啉衍生物及其用于治疗良性和恶性肿瘤疾病的用途
-
申请号： US12731243申请日： 2010-03-25
-
公开(公告)号： US08394801B2公开(公告)日： 2013-03-12
- 发明人: Matthias Gerlach , Irene Seipelt , Eckhard Guenther , Tilmann Schuster , Emmanuel Polymeropoulos , Michael Czech , Eckhard Claus
- 申请人： Matthias Gerlach , Irene Seipelt , Eckhard Guenther , Tilmann Schuster , Emmanuel Polymeropoulos , Michael Czech , Eckhard Claus
- 申请人地址： DE Frankfurt am Main
- 专利权人： Aeterna Zentaris GmbH
- 当前专利权人： Aeterna Zentaris GmbH
- 当前专利权人地址： DE Frankfurt am Main
- 代理机构： Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- 优先权： EP09157141 20090402
- 主分类号： A61K31/495
- IPC分类号： A61K31/495
摘要：
The invention provides quinoxalines of the general formula I which are used as medicaments preferably for treating tumour disorders, in particular in cases of drug resistance to other active compounds and in cases of metastasic carcinoma. The possible applications are not limited to tumour disorders.
公开/授权文献
信息查询
